Publications by authors named "Max Salm"

Claim this Profile
A
A modular protein language modelling approach to immunogenicity prediction.
Hugh O'Brien, Max Salm, Laura T Morton, Maciej Szukszto, Felix O'Farrell

PLoS Comput Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Breaking the performance ceiling for neoantigen immunogenicity prediction.
Hugh O'Brien, Max Salm, Laura T Morton, Maciej Szukszto, Felix O'Farrell

Nat Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking the performance ceiling for neoantigen immunogenicity prediction.
Hugh O'Brien, Max Salm, Laura T Morton, Maciej Szukszto, Felix O'Farrell

Nat Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer.
Jane Robertson, Max Salm, Markus Dangl

Immunooncol Technol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Samra Turajlic, Hang Xu, Kevin Litchfield, Andrew Rowan, Stuart Horswell, Max Salm

Cell· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking the Evolution of Non-Small-Cell Lung Cancer.
Mariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, Nicolai J Birkbak, Thomas B K Watkins, Max Salm

N Engl J Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
Nirupa Murugaesu, Gareth A Wilson, Nicolai J Birkbak, Thomas Watkins, Nicholas McGranahan, Max Salm

Cancer Discov· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.
Michal Kovac, Carolina Navas, Stuart Horswell, Max Salm, Chiara Bardella

Nat Commun· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data.
Ingrid M Lönnstedt, Franco Caramia, Jason Li, Debora Fumagalli, Roberto Salgado, Max Salm

Genome Biol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution.
Elza C de Bruin, Nicholas McGranahan, Richard Mitter, Max Salm, David C Wedge

Science· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
Mariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, Jacqueline Shaw, Caroline Dive, Max Salm

PLoS Biol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.
Marco Gerlinger, Stuart Horswell, James Larkin, Andrew J Rowan, Max P Salm

Nat Genet· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients.
Stuart D Horswell, Lee G D Fryer, Claire E Hutchison, Dlear Zindrou, Helen E Speedy, Max P A Salm

J Lipid Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis